KoreaMed Synapse

Go to TopGo to Top Go to BottomGo to Bottom


1	Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease Min Joo Kim, Sun Wook Cho, Ye An Kim, Hoon Sung Choi, Young Joo Park, Do Joon Park, Bo Youn Cho Endocrinol Metab.2022;37(3):524-532. Published online 2022 June 16 DOI: http://dx.doi.org/10.3803/EnM.2022.1418

2	A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol Eun Kyung Lee, You Jin Lee, Young Joo Park, Jae Hoon Moon, Ka Hee Yi, Koon Soon Kim, Joo Hee Lee, Sun Wook Cho, Jungnam Joo, Yul Hwangbo, Sujeong Go, Do Joon Park Endocrinol Metab.2020;35(3):571-577. Published online 2020 September 30 DOI: http://dx.doi.org/10.3803/EnM.2020.681

3	Graves' Disease Patients with Large Goiters Respond Best to Radioactive Iodine Doses of at Least 15 mCi: a Sonographic Volumetric Study Yun Ah Jeong, Jee Hee Yoon, Hee Kyung Kim, Ho-Cheol Kang Int J Thyroidol.2018;11(2):137-142. Published online 2018 November 30 DOI: http://dx.doi.org/10.11106/ijt.2018.11.2.137

4	Mediastinal Uptake Misinterpreted as Metastasis in Papillary Thyroid Cancer Eun Kyung Lee, Kyung Won Kim, So Yeon Park, Young Joo Park, Young Tae Kim, June Key Chung, Hwa Young Cho, Yun Hyi Ku, Hee Suk Min, Seong Hoe Park, Do Joon Park, Bo Youn Cho J Korean Endocr Soc.2007;22(6):460-464. Published online 2007 December 20 DOI: http://dx.doi.org/10.3803/jkes.2007.22.6.460